SecBot SecBot
3 ·Filed Apr 28, 2026

SKYE

Skye Bioscience, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001628280-26-028062
Form 3, initial insider ownership statement
Actionable Insight • Neutral

Routine CFO onboarding filing with zero ownership disclosed. No trading signal. Monitor future Form 4 filings for insider buying or selling activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.8940
T+0 close · Apr 28, 2026 · via day close
Latest settled
−27.08%
T+60 · $0.6519
Vs SPY
−31.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 29 $0.8940entry
  2. T+1 · 7mo ago −1.68%α −2.70% · $0.8790
  3. T+5 · 7mo ago −4.81%α −7.92% · $0.8510
  4. T+20 · 6mo ago −4.92%α −10.97% · $0.8500
  5. T+60 · 4mo ago −27.08%α −31.19% · $0.6519

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

John P. Sharp filed a Form 3 initial statement of beneficial ownership, reporting no securities owned, in connection with his appointment as Chief Financial Officer of Skye Bioscience, Inc. This is a routine administrative filing for a new officer with no financial data or trading activity disclosed.

Key Facts

  • John P. Sharp appointed Chief Financial Officer of Skye Bioscience, Inc.
  • Form 3 filed on 2026-04-28, reporting period 2026-03-31
  • Reporting person owns 0 shares of common stock
  • No derivative securities reported

Financial Impact

No financial impact, zero securities reported

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001628280-26-028062
Document: 0001628280-26-028062-index-headers.html0001628280-26-028062
Document: 0001628280-26-028062-index.html0001628280-26-028062
Document: 0001628280-26-028062.txt0001628280-26-028062

Track record

16 reports on SKYE

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +82.80% at T+60 after the Aug 14, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago DEFA14A Neutral 3/10 Entry $1.08 Now $1.07 −1.39% settles Dec 11
  2. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $1.08 Now $1.07 −1.39% settles Dec 11
  3. Oct 26, 202621d ago PREM14A Bearish 7/10 Entry $1.45 Now $1.07 +26.55% settles Nov 24
  4. Oct 14, 20264w ago SC 13G Neutral 4/10 Entry $1.59 to $1.08 Now $1.07 −33.02% ▼ −32.08% −30.17% vs SPY
  5. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $1.67 to $1.54 Now $1.07 −36.23% ▼ −7.78% −6.31% vs SPY
  6. Sep 24, 20267w ago SC 13D/A Bearish 6/10 Entry $1.67 to $1.54 Now $1.07 +36.23% ▲ +7.78% +6.31% vs SPY
  7. Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $1.78 to $1.53 Now $1.07 +40.17% ▲ +14.04% +13.14% vs SPY
  8. Aug 19, 202612w ago DEFA14A Neutral 4/10 Entry $0.2809 to $0.2206 Now $1.07 +279.14% ▼ −21.46% −21.34% vs SPY
  9. Aug 14, 202613w ago 8-K Mixed 7/10 Entry $0.5015 to $0.2487 Now $1.07 +112.36% ▼ −50.40% −48.41% vs SPY
  10. Aug 14, 202613w ago Press Release Bearish 7/10 Entry $0.5015 to $0.2487 Now $1.07 −112.36% ▲ +50.40% +48.41% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026